Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 1 de 1
Filtrar
Mais filtros

Base de dados
Ano de publicação
Tipo de documento
País de afiliação
Intervalo de ano de publicação
1.
Rinsho Ketsueki ; 51(12): 1769-74, 2010 Dec.
Artigo em Japonês | MEDLINE | ID: mdl-21258187

RESUMO

We report a case of a 46-year-old female demonstrating general fatigue and visual disturbances with retinal bleeding. She had a white blood cell count of 419,300/mm. Thereafter, she developed vomiting associated with vertigo caused by cerebellar hemorrhage, deteriorating to acute hydrocephalus secondary to obstruction of the cerebral aqueduct. Emergency procedures for cerebral protection, such as hyperventilation, administration of mannitol, and barbiturate coma, were performed. Bone marrow examination showed a positive BCR-ABL/t(9;22)(q34;q11) chromosomal translocation detected by FISH and RT-PCR (masked Ph) and she was diagnosed as having chronic myeloid leukemia (CML) in the chronic phase (CP). She was administered Ara-C, together with imatinib 600 mg/d through a nasogastric tube. Eight days later, she underwent successful extubation and recovered without any neurological defect. She was maintained on imatinib 400 mg/d and demonstrated a major molecular response at 15 months. Physicians need to be aware that brain hemorrhage may develop as an initial symptom of CML patients in CP.


Assuntos
Antineoplásicos/administração & dosagem , Cerebelo , Hemorragia Cerebral/etiologia , Hemorragia Cerebral/terapia , Cuidados Críticos , Hidrocefalia/etiologia , Hidrocefalia/terapia , Leucemia Mielogênica Crônica BCR-ABL Positiva/complicações , Leucemia Mielogênica Crônica BCR-ABL Positiva/terapia , Piperazinas/administração & dosagem , Pirimidinas/administração & dosagem , Doença Aguda , Benzamidas , Terapia Combinada , Citarabina/administração & dosagem , Quimioterapia Combinada , Feminino , Humanos , Mesilato de Imatinib , Leucemia Mielogênica Crônica BCR-ABL Positiva/diagnóstico , Leucostasia/complicações , Manitol/administração & dosagem , Pessoa de Meia-Idade , Respiração Artificial
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA